Evidence map›Paper›PMID 28597116›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2017

Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.

Daniel Svensson, Alexandra Aidoukovitch, Emma Anders, Daniel Jönsson, Daniel Nebel, Bengt-Olof Nilsson

Open access · hybridAbstract read
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Single Cell RNA Sequencing Reveals Critical Functions ofFrontiers in cell and developmental biology · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daniel SvenssonDepartment of Experimental Medical Science, Lund University, BMC D12, 221 84, Lund, Sweden.
Alexandra AidoukovitchDepartment of Experimental Medical Science, Lund University, BMC D12, 221 84, Lund, Sweden.
Emma AndersDepartment of Experimental Medical Science, Lund University, BMC D12, 221 84, Lund, Sweden.
Daniel JönssonDepartment of Experimental Medical Science, Lund University, BMC D12, 221 84, Lund, Sweden.
Daniel NebelDepartment of Experimental Medical Science, Lund University, BMC D12, 221 84, Lund, Sweden.
Bengt-Olof NilssonDepartment of Experimental Medical Science, Lund University, BMC D12, 221 84, Lund, Sweden. bengt-olof.nilsson@med.lu.se.ORCID http://orcid.org/0000-0003-2337-8412
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRegulation of immune-like cell properties of periodontal ligament (PDL) cells is not understood. We investigate the importance of secretory leukocyte protease inhibitor (SLPI) for production of pro-inflammatory cytokines in human PDL cells. MATERIALS AND

methodsPDL cells were isolated from teeth extracted for orthodontic reasons. Cellular location of SLPI was investigated by immunocytochemistry. Cytokine transcript and protein expression were assessed by quantitative real-time RT-PCR and Western blotting. SLPI gene activity was knocked-down by siRNA. NF-κB signaling was assessed by measuring IκBα, and phosphorylated p65 and p105 protein expression.

resultsPDL cells showed cytoplasmic expression of SLPI. Cellular expression level of SLPI negatively correlated to LPS-induced stimulation of IL-6 and MCP-1. Both SLPI gene activity and protein were reduced by about 70% in PDL cells treated with SLPI siRNA compared to cells treated with non-coding construct. Treatment with SLPI siRNA was associated with up-regulation of both basal and LPS-stimulated IL-6, MCP-1 and TLRs mRNA expression. The up-regulation of MCP-1 transcript in SLPI siRNA-treated cells was confirmed on protein level. SLPI siRNA-treatment enhanced the phosphorylated NF-κB p105 protein expression.

conclusionsSLPI regulates PDL cell pro-inflammatory cytokine expression and modulates NF-κB signaling, suggesting that SLPI governs the immune cell-like properties of PDL cells.

Indexed as

AdolescentCell LineCells, CulturedChemokine CCL2ChildCoculture TechniquesFemaleHumansInterleukin-6LipopolysaccharidesMaleNF-kappa BPeriodontal LigamentRNA, MessengerRNA, Small InterferingSecretory Leukocyte Peptidase InhibitorCCL2 protein, humanChemokine CCL2IL6 protein, humanInterleukin-6LipopolysaccharidesNF-kappa BRNA, MessengerRNA, Small InterferingSecretory Leukocyte Peptidase InhibitorSlpi protein, mouseTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4CytokinesNF-κBPeriodontal ligament cellsPeriodontitisSecretory leukocyte protease inhibitor

Identifiers

PMID28597116
PMCPMC5529494
OpenAlexW2621678333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.